Entry |
|
Name |
Verapamil (USAN/INN) |
Formula |
C27H38N2O4
|
Exact mass |
454.2832
|
Mol weight |
454.60
|
Structure |

|
Simcomp |
|
Class |
Cardiovascular agent
DG01575 Calcium channel blocker
DG01496 Calcium channel L type blocker
DG01653 Antiarrhythmics
DG01807 Phenylalkylamine derivative
Metabolizing enzyme substrate
DG01633 CYP3A/CYP3A4 substrate
DG02913 CYP3A4 substrate
Metabolizing enzyme inhibitor
DG02852 CYP3A/CYP3A4 inhibitor
DG01522 CYP3A4 inhibitor
Transporter substrate
DG01665 ABCB1 substrate
Transporter inhibitor
DG01622 ABCB1 inhibitor
|
Remark |
Product (DG00329): | D00619<JP/US> |
|
Efficacy |
Antiarrhythmic, Vasodilator, Calcium channel blocker |
Comment |
Phenylalkylamine derivative
|
Target |
|
Pathway |
hsa04270 | Vascular smooth muscle contraction |
|
Metabolism |
Enzyme: CYP3A4 [HSA: 1576]
Transporter: ABCB1 [HSA: 5243]
|
Interaction |
CYP inhibition: CYP3A4 [HSA: 1576]
Transporter inhibition: ABCB1 [HSA: 5243]
|
Structure map |
|
Other map |
|
Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
C CARDIOVASCULAR SYSTEM
C08 CALCIUM CHANNEL BLOCKERS
C08D SELECTIVE CALCIUM CHANNEL BLOCKERS WITH DIRECT CARDIAC EFFECTS
C08DA Phenylalkylamine derivatives
C08DA01 Verapamil
D02356 Verapamil (USAN/INN)
Drug groups [BR:br08330]
Cardiovascular agent
DG01575 Calcium channel blocker
DG01496 Calcium channel L type blocker
DG00329 Verapamil
D02356 Verapamil
DG01653 Antiarrhythmics
DG01807 Phenylalkylamine derivative
DG00329 Verapamil
D02356 Verapamil
Metabolizing enzyme substrate
DG01633 CYP3A/CYP3A4 substrate
DG02913 CYP3A4 substrate
DG00329 Verapamil
D02356 Verapamil
Metabolizing enzyme inhibitor
DG02852 CYP3A/CYP3A4 inhibitor
DG01522 CYP3A4 inhibitor
DG00329 Verapamil
D02356 Verapamil
Transporter substrate
DG01665 ABCB1 substrate
DG00329 Verapamil
D02356 Verapamil
Transporter inhibitor
DG01622 ABCB1 inhibitor
DG00329 Verapamil
D02356 Verapamil
Target-based classification of drugs [BR:br08310]
Ion channels
Voltage-gated ion channels
Calcium channels
CACNA1-L
D02356 Verapamil (USAN/INN)
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D02356
Drug transporters
D02356
Drug groups [BR:br08330]
Cardiovascular agent
DG01575 Calcium channel blocker
DG01496 Calcium channel L type blocker
DG00329 Verapamil
DG01653 Antiarrhythmics
DG01807 Phenylalkylamine derivative
DG00329 Verapamil
Metabolizing enzyme substrate
DG01633 CYP3A/CYP3A4 substrate
DG02913 CYP3A4 substrate
DG00329 Verapamil
Metabolizing enzyme inhibitor
DG02852 CYP3A/CYP3A4 inhibitor
DG01522 CYP3A4 inhibitor
DG00329 Verapamil
Transporter substrate
DG01665 ABCB1 substrate
DG00329 Verapamil
Transporter inhibitor
DG01622 ABCB1 inhibitor
DG00329 Verapamil
|
Other DBs |
|
LinkDB |
|
KCF data |
ATOM 33
1 C1d C 21.2293 -18.3108
2 C8y C 20.0265 -19.0115
3 C1b C 22.4436 -19.0056
4 C1c C 21.2001 -16.9563
5 C8x C 18.8122 -18.3108
6 C8x C 20.0265 -20.4125
7 C1b C 23.6580 -18.3049
8 C1a C 22.4146 -16.2441
9 C1a C 19.9916 -16.2557
10 C8y C 17.5979 -19.0115
11 C8x C 18.8122 -21.1190
12 C1b C 24.8665 -18.9939
13 C8y C 17.5979 -20.4125
14 O2a O 16.3778 -18.3108
15 N1c N 26.0808 -18.2991
16 O2a O 16.3778 -21.1190
17 C1a C 15.1634 -19.0115
18 C1b C 27.2951 -18.9881
19 C1a C 26.0808 -16.8455
20 C1a C 15.1634 -20.4183
21 C1b C 28.5094 -18.2932
22 C8y C 29.7120 -18.9822
23 C8x C 30.9265 -18.2815
24 C8x C 29.6480 -20.3775
25 C8y C 32.1351 -18.9764
26 C8x C 30.9322 -21.0781
27 C8y C 32.1409 -20.3716
28 O2a O 33.3493 -18.2700
29 O2a O 33.3610 -21.0722
30 C1a C 34.5695 -18.9647
31 C1a C 34.5752 -20.3658
32 C3b C 21.2293 -19.7108
33 N3a N 21.2293 -21.1108
BOND 34
1 1 2 1
2 1 3 1
3 1 4 1
4 2 5 2
5 2 6 1
6 3 7 1
7 4 8 1
8 4 9 1
9 5 10 1
10 6 11 2
11 7 12 1
12 10 13 2
13 10 14 1
14 12 15 1
15 13 16 1
16 14 17 1
17 15 18 1
18 15 19 1
19 16 20 1
20 18 21 1
21 21 22 1
22 22 23 1
23 22 24 2
24 23 25 2
25 24 26 1
26 25 27 1
27 25 28 1
28 27 29 1
29 28 30 1
30 29 31 1
31 11 13 1
32 26 27 2
33 1 32 1
34 32 33 3
|